FT商学院

US pins faith on Pfizer’s ‘living with Covid’ pill
美国寄望于辉瑞的“与新冠共存”药

The antiviral drug Paxlovid is being widely prescribed but there are questions about its effectiveness
抗病毒药物Paxlovid正被广泛使用,但其有效性仍存在疑问。

Late last year it looked like a key to “living with Covid” had finally been found. Pfizer’s antiviral drug Paxlovid had been approved, giving the newly infected the option of popping a pill to tackle their symptoms, cutting hospitalisations and other damaging effects of the disease.

去年年底,人们似乎终于找到了“与新冠共存”的关键。辉瑞的抗病毒药物Paxlovid获批,使新感染者可以选择吃药来解决他们的症状,减少住院和该疾病的其他破坏性影响。

您已阅读4%(364字),剩余96%(9976字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×